77.1 F
Saturday, May 25, 2024

Future of Neurosurgery Emerging with Steady Adoption of New Technology

More by this author

SAN FRANCISCO — Indianapolis medical device maker NICO Corporation has witnessed steady adoption of its BrainPath® technology with more than 130 neurosurgeons CME trained and nearly 40 institutions fully operational with the new integrated systems approach to neurosurgery. The technology will be featured at this week’s American Association of Neurological Surgeons annual scientific meeting in San Francisco.

More than 550 successful surgeries have been performed since the new 6 Pillar Approach using the NICO BrainPath was introduced, giving a new surgical option to patients in accessing emergent and hard to reach brain abnormalities.

“We have now surpassed the ‘proof of concept’ stage as validated by the outcomes we are seeing using the BrainPath and other new technologies in imaging, navigation and optics,” said Jim Pearson, president and CEO of NICO Corporation. “This is an extremely underdeveloped market segment with many patients not having surgical options when they are told they have a brain abnormality. Our mission as a company is to change this.”

Pearson explained that other technologies have been developed because surgery was not an option due to the inability to access and remove tissue. “We believe these limitations and deficiencies are now solved with this new multi-disciplinary approach that the BrainPath is used in. This is a true revolution in neurosurgery and we are happy to play a role in its advancement.”

Among the institutions designated as BrainPath Centers with surgeons trained to use the BrainPath are: Johns Hopkins, Cleveland Clinic, Iowa Methodist, Duke University, Aurora Health Systems, University of Arkansas, Stanford, Cancer Treatment Centers of America, Houston Methodist, Long Island Jewish, Evanston NorthShore University, Holy Cross Hospital, St. Vincent Health (Ind.), Indiana University Health, University of Virginia, Illinois Neurological Institute, and Marquette General Hospital.

Each year, it is estimated that 50 percent of the more than 450,000 patients in the U.S. diagnosed with brain abnormalities have limited surgical options available to them. Worldwide, these numbers increase to 2 million.

For more information about NICO Corporation or the NICO BrainPath and other NICO products, visit www.NICOneuro.com 

- Advertisement -

Upcoming Online Townhalls

- Advertisement -

Subscribe to our newsletter

To be updated with all the latest local news.

Stay connected


Related articles

Popular articles

Español + Translate »
Skip to content